Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Pricer and Focal Systems Announce Strategic Collaboration to Drive the Next Step in Physical Store Digitalization

Pricer, a global leader in digital shelf-edge solutions, and Focal Systems, a leader in shelf-edge AI, today announced a strategic collaboration to accelerate the digitization and optimization of the physical store for retailers worldwide.This collaboration brings together Pricer’s innovations in dynamic pricing and shelf-edge communication with Focal Systems’ advanced computer vision and product availability solutions to maximize shopper satisfaction while optimizing retail operations. As a pioneer in enabling dynamic pricing and digitizing shelf-edge shopper communication, Pricer has

BlueNord: Update on Tyra Redevelopment Project

Oslo, 11 January 2025: Reference is made to stock exchange notice published by BlueNord ASA ("BlueNord" or the "Company") on 19 December 2024 where the Company gave an update on the Tyra Redevelopment Project (“Tyra II”) and expected plateau production to be reached in the second half of January 2025. The operator of the Danish Underground Consortium (the “DUC”), TotalEnergies, is undertaking work to replace a seal on a gas compressor and Tyra II is therefore not currently running at full technical capacity, however once the work is completed the operator expects full technical capacity

Reliable Casino Payment Methods 2025: Insights from OnlineCasinoRank

Stockholm, Sweden, January 2025 – OnlineCasinoRank, a trusted name in the online gambling industry, has released an in-depth analysis of the most reliable payment methods for online casino players in 2025. From PayPal to prepaid cards, the focus remains on ensuring safe, fast, and user-friendly transactions for players worldwide.Why Payment Methods Matter in Online Gambling The choice of payment method is critical in enhancing player satisfaction and trust. Secure and efficient payment options not only allow players to deposit and withdraw funds seamlessly but also build confidence in

Nordea Bank Abp: Repurchase of own shares on 10.01.2025

Nordea Bank AbpStock exchange release – Changes in company’s own shares10.01.2025 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 10.01.2025 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |139,792|10.91 |1,524,851.

Ghosts of Tabor Announces First-Ever Twitch Drops Event Coming January 24-27

MEDIA ALERT - Beyond Frames Entertainment and Combat Waffle Studios today announced that, in collaboration with Twitch, Ghosts of Tabor will host its first Twitch Drops event from 11 am EST on Friday, January 24 through 8 am EST on Monday, January 27. An interactive experience rewarding viewers and streamers alike, Twitch Drops events unlock virtual goodies and in-game items for viewers of Drops-enabled livestreams.  “Viewership for VR titles is growing by leaps and bounds on Twitch, with more and more players curious about what immersive play really looks like, and the kind of

Fitch Lowers Rating to ’B-’ for Heimstaden AB, Revises Outlook to Rating Watch Negative

Fitch lowers Heimstaden AB’s Long-Term Issuer Default rating (IDR) to ‘B-‘ and revises the Outlook to Rating Watch Negative (RWN) from Negative. Today Fitch stated “Heimstaden AB’s RWNs reflect the execution risk of its bond issuance planned for 1Q25 together with today’s tender offer to repay bonds maturing in 2025 and 2026. An unsuccessful bonds issuance will result in refinancing risk for its October 2025 bond, pointing to a rating downgrade. A successful bonds issuance leading to sufficient liquidity until its March 2027 refinancing risk, may result in an affirmation of the IDR with

Fitch Affirms Investment Grade Rating of ’BBB-’ for Heimstaden Bostad, Raised Outlook to Stable

Fitch affirms Heimstaden Bostad’s Long-Term Issuer Default rating (IDR) of ‘BBB-‘ and raises the Outlook to Stable from Negative.Co-CEO Christian Fladeland comments:  "The stable outlook validates that Heimstaden Bostad continues to deliver on its base case performance which includes stronger than ever operational results supported by stabilised credit metrics. We remain committed to taking prudent measures to return to a ‘BBB’ rating.”

Klaria signs license agreement for Sumatriptan Alginate film in Europe with CNX Therapeutics

Klaria Pharma Holding AB (publ) ("Klaria" or the "Company") announces that the Company has signed a license agreement for Sumatriptan Alginate Film (the "Product"), a pharmaceutical product based on Klaria's patented alginate films for fast and reliable administration via the oral mucosa, which is approved in Germany, Spain and Italy for the treatment of migraine with or without aura, with CNX Therapeutics Limited (“CNX Therapeutics”). The agreement gives CNX Therapeutics the right to market and sell the Product in Europe and the UK under its own brand and product name, and the parties plan

Panoro Energy ASA - Announces Transactions Made Under the Company’s Share Buyback Program

Oslo, 10 January 2025 – Panoro Energy ASA (“Panoro” or the “Company”) (OSE: PEN) initiated a share buyback program on May 23, 2024 to repurchase up to NOK 100 million in value of the Company’s common shares in open market transactions on the OSE pursuant to an agreement with Arctic Securities AS. For the period from and including 02 January – 10 January 2025, Panoro purchased a total of 107,700 shares at an average price of NOK 28.9444 per share. The transactions effected through the agreement with Arctic comprise all the transactions effected by or on behalf of the Company during the

Sobi's full year 2024 revenue higher than previous estimate

Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today that revenue for the full year 2024 was higher than previous estimate. Full-year revenue was approximately SEK 26,000 M, representing approximately 19% growth at constant exchange rate (CER) (1). Adjusted EBITA margin (1,2) was in the mid-30s per cent of revenues.The main reasons for the increased revenue are higher sales than expected in Q4 across the Haemophilia portfolio and for Kineret. · Altuvoct: Higher than expected rate of new patients switching to Altuvoct in markets where the product has been launched,

SlotsRank Explores Top Branded Slot Games

Stockholm, Sweden – January 2025 – SlotsRank, a renowned platform for online slot reviews and rankings, has released its latest insights into branded slot games, a category redefining the online casino landscape. By combining globally recognized franchises with innovative slot mechanics, branded slots have emerged as a favorite among players seeking immersive gaming experiences.These unique games integrate elements from popular culture, including movies, TV shows, and music, to offer players an unparalleled connection to their favorite stories and characters. SlotsRank’s initiative aims to

ABAX disputes Greater Than’s claims in its entirety

Larvik (Norway), January 10, 2025 - In reference to the press release of January 10th issued by Greater Than, accusing ABAX of infringing upon contractually regulated intellectual property (IP) rights, ABAX categorically refutes these allegations. ABAX find it necessary to address the statements made, as these claims are not only unfounded but misrepresentative of the facts. With reference to the already ongoing and now indicated litigations, ABAX will refrain from making any further comments at this time.

Read original

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 10.01.2025

Fiskars Corporation   Stock Exchange Release 10.01.2025 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 10.01.2025   Date 10.01.2025  Exchange transaction Buy  Share class FSKRS  Amount  2000  Average price/share 14.7915 EURHighest price/share 14.8200 EURLowest price/share 14.7400 EURTotal price 29,583.00 EUR      The share buybacks are executed in compliance with Regulation No. 596/2014 of the European

#25-8 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

STENOCARE A/S announces guarantee commitments in ongoing rights issue

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENO STENOCARE A/S (“Stenocare” or the “Company”) announces that the Company has received a legally binding guarantee commitment of 2 mDKK from Exelity AB, securing approximately 9.9 percent of the total issue corresponding to approximately 22.0 percent of the minimum subscription. As stated in the announcement of 18 December 2024, the Company has also received legally binding written pre-subscription commitments and compensation-free guarantees from management and existing shareholders of 1.5 mDKK, corresponding to

Symrise’s recommended offer to the shareholders of Probi expires soon; regulatory approval received

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in, any jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares in the Offer would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law.Press release 10 January 2025   On 20 November 2024, Symrise AG (“Symrise”) announced a

2025 Roadmap: Boomerang Partners Targets Growth in iGaming

Boomerang Partners  has shared its plans for 2025. This rapidly growing global company is preparing for new products and global expansion. After a successful 2024, it is ready to strengthen its position in iGaming with a key focus on sports betting. Boomerang is dedicated to empowering its business partners with the motto: "Live Without Limits," offering boundless opportunities for growth and success.Business Growth Objectives Boomerang has global plans to increase business performance. For these

THOMSON ADDS ENCODER OPTION TO STEPPER MOTOR LINEAR ACTUATOR ONLINE SELECTION TOOL

Editorial Contact: Priya Sharma – +44 (0) 203 965 7415Company Contact: Kevin Bastian – +1 630 694 3342 Please quote the following contact information when publishing:Tel.: 540.633.3549, Fax: 540.633.0294, www.thomsonlinear.com; Thomson@regalrexnord.com01.08.2024, DOWNERS GROVE, IL – Thomson Industries, Inc., a leading manufacturer of linear motion control solutions, has announced a significant upgrade to its stepper motor linear actuator (SMLA) online selector tool, adding the ability to include encoders in the design process. The new option streamlines the design and purchasing

Invitation to monthly digital events and presentations of quarterly report

Hamlet BioPharma is pleased to announce the continuation of the digital event series in the spring of 2025. These events provide participants a valuable opportunity to follow and discuss our drug development process and engage directly with our team during the Q&A sessions that will follow each presentation. Please visit our web to join the digital events: https://hamletbiopharma.com/series-of-digital-events   The digital events are scheduled for:   · January 22, 2025, 12:00 CET · March 12, 2025, 12:00 CET · April 23, 2025, 12:00 CET · June 18, 2025, 12:00 CET

CS MEDICA Achieves Fourth European Patent with Psoriasis Gel

Strengthening Competitive Edge and Driving InnovationCS MEDICA announces the achievement of its fourth European patent, this time for its Psoriasis Gel, which is already MDR-approved. This milestone underscores the company’s dedication to delivering innovative, science-backed treatments and further solidifies its competitive edge in the MedTech sector. The patent reinforces CS MEDICA’s market position and elevates the company’s value as an innovative player in the MedTech industry, proving its resilience and commitment to growth despite challenges faced as a scale-up company. For more

There are no items matching the current filter
There are no more items matching the current filter
Back to top